BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37168738)

  • 1. Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity.
    Ngo HV; Bak HE; Nguyen HD; Lee KW; Park C; Lee BJ
    Int J Nanomedicine; 2023; 18():2325-2344. PubMed ID: 37168738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyl Group-Targeted Conjugate and Its Self-Assembled Nanoparticle of Peptide Drug: Effect of Degree of Saturation of Fatty Acids and Modification of Physicochemical Properties.
    Park J; Ngo HV; Jin HE; Lee KW; Lee BJ
    Int J Nanomedicine; 2022; 17():2243-2260. PubMed ID: 35615542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Leuprolide-Fatty Acid Conjugate in Rat Plasma Using LC-MS/MS and Its Pharmacokinetics after Subcutaneous Administration in Rats.
    Seong GS; Seo SW; Cho JY; Lee KW; Lee BJ; Yoon IS; Jin HE
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Fatty Acid Chain Length and Enzyme-Oriented Drug Controlled Release from pH-Triggering Self-Assembled Fatty Acid Conjugated Quetiapine Nanosuspensions.
    Nguyen HD; Ngo HV; Nguyen VH; Gil MC; Lee BJ
    Int J Nanomedicine; 2023; 18():7115-7131. PubMed ID: 38054081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the fatty acid chain length on in vitro and in vivo anticancer activity of fattigation-platform albumin nanoparticles in human colorectal cancer xenograft mice model.
    Park C; Baek N; Loebenberg R; Lee BJ
    J Control Release; 2020 Aug; 324():55-68. PubMed ID: 32380202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.
    Pappa EV; Zompra AA; Spyranti Z; Diamantopoulou Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
    Biopolymers; 2011; 96(3):260-72. PubMed ID: 20632397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.
    Katsila T; Balafas E; Liapakis G; Limonta P; Montagnani Marelli M; Gkountelias K; Tselios T; Kostomitsopoulos N; Matsoukas J; Tamvakopoulos C
    J Pharmacol Exp Ther; 2011 Mar; 336(3):613-23. PubMed ID: 21106905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive buccal tablet of leuprolide and its fatty acid conjugate: Design, in vitro evaluation and formulation strategies.
    Jin H; Ngo HV; Park C; Lee BJ
    Int J Pharm; 2023 May; 639():122963. PubMed ID: 37068715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of the GnRH type 1 receptor blocks the antiproliferative effect of the GnRH agonist, leuprolide, on the androgen-independent prostate cancer cell line DU145.
    Ko YH; Ha YR; Kim JW; Kang SG; Jang HA; Kang SH; Park HS; Cheon J
    J Int Med Res; 2011; 39(3):729-39. PubMed ID: 21819703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of short and long chain fatty acids on physicochemical properties and improved cancer targeting of albumin-based fattigation-platform nanoparticles containing doxorubicin.
    Park C; Meghani N; Amin H; Tran PH; Tran TT; Nguyen VH; Lee BJ
    Int J Pharm; 2019 Jun; 564():124-135. PubMed ID: 30991133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
    Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
    Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
    Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
    Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression.
    Cucchiara V; Yang JC; Liu C; Adomat HH; Tomlinson Guns ES; Gleave ME; Gao AC; Evans CP
    Mol Cancer Ther; 2019 Oct; 18(10):1811-1821. PubMed ID: 31341032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute gonadotropin-releasing hormone agonist treatment enhances extinction memory in male rats.
    Maeng LY; Taha MB; Cover KK; Glynn SS; Murillo M; Lebron-Milad K; Milad MR
    Psychoneuroendocrinology; 2017 Aug; 82():164-172. PubMed ID: 28550793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated leuprolide with improved pharmacokinetic properties.
    Fu M; Zhuang X; Zhang T; Guan Y; Meng Q; Zhang Y
    Bioorg Med Chem; 2020 Feb; 28(4):115306. PubMed ID: 31926774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin-releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study.
    Chen DY; Su PJ; See LC; Liu JR; Chuang CK; Pang ST; Tseng CN; Chen SW; Hsieh IC; Chu PH; Lin YC; Hsu CL; Chang JW; Lin MS; Pang JS; Hsieh MJ; Huang WK
    Prostate; 2021 Sep; 81(12):902-912. PubMed ID: 34196430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
    Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
    Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanonization and Deformable Behavior of Fattigated Peptide Drug in Mucoadhesive Buccal Films.
    Kim W; Ngo HV; Nguyen HD; Park JM; Lee KW; Park C; Park JB; Lee BJ
    Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
    Teplán I
    Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuprolide acetate: a drug of diverse clinical applications.
    Wilson AC; Meethal SV; Bowen RL; Atwood CS
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1851-63. PubMed ID: 17970643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.